Ah‐Rong Nam

机构：Seoul National University, Seoul National University Hospital

发表论文 52 篇 · 总被引 418 次 · h-index 9

代表论文

• Immunomodulatory effects of trastuzumab deruxtecan through the cGAS-STING pathway in gastric cancer cells (2024 · Cell Communication and Signaling · 被引 23)
• Inhibition of WEE1 Potentiates Sensitivity to PARP Inhibitor in Biliary Tract Cancer (2021 · Cancer Research and Treatment · 被引 14)
• A synthetic lethal strategy using PARP and ATM inhibition for overcoming trastuzumab resistance in HER2-positive cancers (2022 · Oncogene · 被引 13)
• JPI-547, a Dual Inhibitor of PARP/Tankyrase, Shows Antitumor Activity Against Pancreatic Cancers with Homologous Recombination Repair Deficiency or Wnt-Addiction (2025 · International Journal of Biological Sciences · 被引 7)
• Therapeutic potential of BOLD-100, a GRP78 inhibitor, enhanced by ATR inhibition in pancreatic ductal adenocarcinoma (2025 · Cell Communication and Signaling · 被引 5)
• Fadraciclib, a CDK2/CDK9 inhibitor, shows efficacy in biliary tract cancer and synergistic potential with olaparib and JQ1 based on MCL1 expression (2025 · Cell Communication and Signaling · 被引 2)